
Panakès et al. back €9m series-B for Carthera
A group of investors have taken part in a €9m series-B funding round for France-based Carthera, a developer of ultrasound-based medical devices to treat brain disorders.
French VCs Sham Innovation Santé and Supernova Invest, French investment firm Group Arnault, Italy-based VC Panakès Partners and previous investors have backed the business.
Supernova backed the business via its Supernova 2 vehicle, closed on €75m in 2017. Sham Innovation Santé is a venture capital firm advised by Turenne Capital and dedicated to equity investments in health companies.
The proceeds will be used to further advance the SonoCloud technology and develop the clinical pipeline of the company.
Previous funding
France’s ministry of research, the Ile-de-France region, BPI France, Medicen Paris Region and Lyonbiopôle are all historical backers of the business.
Company
Founded in 2010 and based in Paris, Carthera designs and develops therapeutic ultrasound-based medical devices for treating brain disorders. Its SonoCloud product is an intracranial ultrasound implant that temporarily opens the blood-brain barrier.
The company is a spin-off from AP-HP, Greater Paris University Hospitals, a hospital group, and Sorbonne University.
People
CarThera - Alexandre Carpentier (founder), Frederic Sottilini (CEO).
Panakès Partners - Diana Saraceni (general partner).
Turenne Capital - Bervin Bouani (senior associate).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater